Home
Search
Search Results
Previously Searched
3167 results found
Expand All
Apply All
3167 results found

SEC Comment Letter: Request for Comment on Climate Risk Disclosures (6/13/2021)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Comments on SEC request for information on climate risk disclosures.
Read More

Request for Comment on Proposed Amendments to Rules Governing Proxy Voting Advice (12/23/2021)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Comments on proposed rule governing proxy voting advice.
Read More

FTC Comment Letter: Request for Comment on Pharmaceutical Task Force, Project No. P212900 (6/13/2021)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Comments in response to Federal Trade Commission’s Pharmaceutical Task Force’s request for public comment.
Read More

FTC Comment Letter: Request for Information on Merger Enforcement (4/15/2022)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Comments to FTC on merger enforcement.
Read More

FTC Comment Letter: Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers (5/5/2022)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Comments in response to FTC Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers.
Read More

Statement for the Record: "A Roadmap for Growth: Reforms to Encourage Capital Formation and Investment Opportunities for All Americans" (4/23/2023)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Statement for the Record to House Financial Services Committee, Subcommittee on Capital Markets.
Read More

Testimony: "The Impact of Consolidation and Monopoly Power on American Innovation" (12/15/2021)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
Testimony of BIO’s Chief Policy Officer before the Senate Subcommittee on Competition Policy, Antitrust, and Consumer Rights on consolidation and monopoly power.
Read More

BIO Letter of Support: Short Sale Transparency and Market Fairness Act (7/29/2021)
Capital Formation Policy Issues, Educational  •  April 23, 2024
BIO Support of H.R. 4618, to amend short sale reporting requirements.
Read More

BIO Issue Brief: Committee on Foreign Investment in the United States (CFIUS) (9/22/2022)
Capital Formation Policy Issues, Advocacy  •  April 23, 2024
An overview of CFIUS and how the Administration’s focus on protecting the U.S. Biotech Industry could cause unintentional harm by impeding foreign investment and collaborations.
Read More

BIO Letter to Senate Banking Cmte: Proposals to Foster Capital Formation and Economic Growth in the Bioeconomy (3/18/2021)
Capital Formation Policy Issues, ECS Digital Resources  •  April 23, 2024
BIO Letter to Senate Banking Committee in support of proposals to foster capital formation for biotechs.
Read More